Navigation Links
New Data Suggests Interferon-Free Therapy Around the Corner for HCV Patients
Date:4/19/2012

ibavirin (RBV) treatment[10] and in 10-14% of patients, side effects are so severe that treatment must be discontinued.[8],[9]

However, studies have shown that achieving a virologic response in chronic HCV is much more dependent on the dose of IFN-α[11]/PegIFN-α[12],[13],[14] than RBV[15],[16],[17],[11],[18]. As such, PegIFN-α free therapy is highly anticipated by healthcare professionals and patients alike.

EASL's Secretary General Professor Mark Thursz commented on the exciting new data being showcased at the congress: "In the future, patients can look forward to all oral treatment regimens with high success rates and low side effects. Furthermore, there is a large cohort of patients with more advanced liver disease who will now be able to access treatment that was previously impossible due to the side effects of Interferon-alpha. Over the last five years we have seen an evolution in HCV treatment, with direct antivirals used in combination with Pegylated Interferon and Ribavirin. Interferon-free regimes truly represent a revolution in treatment."

Separate data presented at the congress may provide a further option. New results from a phase IIb study[19] show a different form of interferon - pegylated Interferon-lambda (PegIFN-λ) - administered with RBV for 24 weeks in HCV GT2 & 3 patients gives comparable SVR24 (undetectable HCV RNA levels 24 weeks after treatment) to PegIFN-α-2a and RBV, but with fewer side effects (musculoskeletal and flu-like symptoms, hematologic toxicity) and dose modifications for PegIFN or RBV.

Professor Thursz commented: "It remains possible that a number of patients will still need interferon based therapy for their HCV infection. Interferon-lambda, with a better side effect profile, looks like an excellent option in this group of patients, who are likely to have more advanced disease."

Notes to
'/>"/>

SOURCE European Association for the Study of the Liver
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Journal Article Suggests DermaClose® RC Used in Combination With VAC Therapy Can Dramatically Reduce the Need for Skin Grafting of Fasciotomy Wounds for Combat Related Trauma
2. Grifols Study Suggests Repeated Plasmapheresis May Reduce "Bad" LDL Cholesterol Levels While Increasing "Good" HDL Cholesterol Levels in Some Individuals
3. New Research Suggests That Acthar Reduces Proteinuria in Idiopathic Membranous Nephropathy In Part Through Suppression of Anti-PLA2R Antibodies
4. TRiUS Data Suggests That Testim® Significantly Improved Sexual Function in Hypogonadal Men
5. Help Remedies Suggests People TAKE LESS
6. Research Suggests FORTEO® Significantly Increases Bone Strength
7. Food Allergies Common among Children and Linked to Environmental Allergies and Asthma Later in Life, Suggests Largest-Ever National Allergy Study
8. Leading Rehab Facility Urges Patients Not to Stop Taking Antidepressants After New Study Suggests Increased Risk of Heart Attacks and Strokes
9. New Subgroup Analysis of LUX-Lung 1 Trial Suggests Afatinib Increases Progression-Free Survival in Advanced Lung Cancer Patients More Likely to Have EGFR Mutations
10. Data Suggests Positive Pharmacokinetic Results From Phase I Research of Extended-Release Topiramate
11. Analysis of Longer-Term Clinical Study Suggests Psychiatric Hospitalization Rates Decreased in Adults with Schizophrenia Treated With INVEGA® SUSTENNA®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... LAUSANNE , Switzerland , ... part of Debiopharm Group ™ , is proud to ... ™ instrument. Debiopharm Diagnostics is a long-time ... portfolio. Idylla ™ Biocartis, fully ... designed to offer physicians fast and easy access ...
(Date:9/16/2014)... -- This report analyzes the worldwide markets for Animal Medication ... Anti-Infectives, Medicinal Feed Additives, and Others. The report also analyzes ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... and forecasts are provided for the period 2013 through 2020. ...
(Date:9/16/2014)...  Chairman and CEO Bernard J. Tyson ... assume the role of interim chief information officer (CIO) ... immediately. "Kaiser Permanente is a recognized ... the high-quality care and service we provide to our ... has extensive experience in information technology. I am confident ...
Breaking Medicine Technology:Debiopharm Diagnostics Portfolio Company Biocartis Ships its First Idylla Instrument 2Global Animal Medication Industry 2Global Animal Medication Industry 3Global Animal Medication Industry 4Global Animal Medication Industry 5Global Animal Medication Industry 6Global Animal Medication Industry 7Global Animal Medication Industry 8Global Animal Medication Industry 9Global Animal Medication Industry 10Global Animal Medication Industry 11Global Animal Medication Industry 12Global Animal Medication Industry 13Global Animal Medication Industry 14Global Animal Medication Industry 15Global Animal Medication Industry 16Global Animal Medication Industry 17Global Animal Medication Industry 18Global Animal Medication Industry 19Global Animal Medication Industry 20Global Animal Medication Industry 21Global Animal Medication Industry 22Global Animal Medication Industry 23Global Animal Medication Industry 24Global Animal Medication Industry 25Global Animal Medication Industry 26Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals Name Interim Chief Information Officer 2
... Pharmaceuticals, Inc. (Nasdaq: AMPE ), a biopharmaceutical ... (Zertane™ completed two phase III studies, Ampion™-completed ... these drugs and engaged in further drug development, today ... the US Patent Office of an additional patent that ...
... March 19, 2012 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems ... an emerging leader in the development, assembly, marketing ... products, today announced its financial results for the ... (Logo: http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO ) ...
Cached Medicine Technology:Ampio Strengthens Patent Protection for Lead Drug Ampion™ 2Ampio Strengthens Patent Protection for Lead Drug Ampion™ 3Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 2Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 3Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 4Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 5Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 6Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 7Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 8Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 9Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 10Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 11Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 12Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 13Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 14Dehaier Medical Announces 2011 Fourth Quarter and Year End Financial Results 15
(Date:9/17/2014)... progressive decline in signal transduction and insulin release, according ... in Sweden. The finding, which is published in the ... underlying age-related impairment of insulin-producing cells and diabetes. , ... many diseases, and type 2 diabetes is no exception. ... of developing type 2 diabetes if their insulin-producing cells ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 The ... serving Westchester, Putnam and Dutchess Counties in New ... clinical affiliation agreement with the Mount Sinai Health ... providing integrated and coordinated care for the communities ... both Mount Sinai and MKMG will work together ...
(Date:9/17/2014)... September 17, 2014 “North America ... market data on the North America Gynecological Devices ... US dollars, volume (in units) and average prices ... Female Sterilization Devices (Transcervical Sterilization ... and Rings)) , Endometrial Ablation Devices ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Lintelus, ... announced today it has released Lintelus Meeting Version ... meetings and corporate events. The newest release includes ... and document management capabilities and allow a more ... , Lintelus Meeting 3.1 offers product advancements ...
(Date:9/17/2014)... Chesterbrook, PA (PRWEB) September 17, 2014 ... costs and increase efficiency. Today, Pharmacy Healthcare Solutions, ... Reporting, a web-based analysis and forecasting tool that ... while maximizing the impact of medications on improved ... TARxGET Reporting uses pharmacy purchase data to identify ...
Breaking Medicine News(10 mins):Health News:Mechanism behind age-dependent diabetes discovered 2Health News:Mount Sinai Health System Partners with Mount Kisco Medical Group to Enhance Health Care Options for Residents of Lower Hudson Valley 2Health News:Mount Sinai Health System Partners with Mount Kisco Medical Group to Enhance Health Care Options for Residents of Lower Hudson Valley 3Health News:Gynecological Devices Market in North America (US, Canada & Mexico) to 2020 New Report Available at MarketOptimizer.org 2Health News:Gynecological Devices Market in North America (US, Canada & Mexico) to 2020 New Report Available at MarketOptimizer.org 3Health News:Gynecological Devices Market in North America (US, Canada & Mexico) to 2020 New Report Available at MarketOptimizer.org 4Health News:Lintelus Energizes Audiences with the Latest Version Of its Multi-Screen Interactive Software 2Health News:Pharmacy Healthcare Solutions Launches TARxGET™ Reporting 2Health News:Pharmacy Healthcare Solutions Launches TARxGET™ Reporting 3
... ... ... Plastic Surgeons (ASPS) is bringing its popular Hot Topics in Plastic Surgery panel directly to ... can get answers to questions on emerging procedures, trends, and new technologies while engaging in ...
... Oct. 26 With the fall and winter influenza ... Prevention anticipates an even greater impact than the spring ... and businesses affected. SunGard Availability Services today outlined the ... addressed in developing pandemic plans to improve ...
... SOUTH PASADENA, Calif., Oct. 26 An evening under ... hundreds of distinguished guests from the State, local cities ... Cancer Center officially opened with a ceremonial ribbon cutting ... Antonovich and California Assemblymember Ted Lieu paid special recognition ...
... in 30 children and young adults shows good early ... with certain heart defects have impaired blood flow from ... the lungs, requiring implanted devices (known as right-ventricular outflow ... fail over time, and children typically face multiple open-heart ...
... , FARMINGTON HILLS, Mich., Oct. 26 ... flu will cause them to avoid shopping on traditionally busy retail ... Omnibus Study. , This concern stems from a consumer fear of ... the last 12 months. Some of the Morpace respondents indicated that ...
... Research Inc. (TSX:NRI), today responded to a request from ... behalf of the Toronto Stock Exchange following recent trading ... policy not to comment on market rumours or speculation, ... as previously disclosed, it anticipates receiving a decision from ...
Cached Medicine News:Health News:Plastic Surgeons to Discuss Cleavage Rejuvenation, Do-It-Yourself Lasers and Other Hot Topics with the Media 2Health News:SunGard Availability Services Addresses the Business, Operational and Workforce Issues Involved in Pandemic Planning 2Health News:SunGard Availability Services Addresses the Business, Operational and Workforce Issues Involved in Pandemic Planning 3Health News:SunGard Availability Services Addresses the Business, Operational and Workforce Issues Involved in Pandemic Planning 4Health News:South Pasadena Cancer Center Grand Opening Brings State and City Officials Together for an Evening 2Health News:Catheter-Delivered Valve May Help People With Heart Defects Avoid Multiple Surgeries 2Health News:Catheter-Delivered Valve May Help People With Heart Defects Avoid Multiple Surgeries 3Health News:Catheter-Delivered Valve May Help People With Heart Defects Avoid Multiple Surgeries 4Health News:Morpace Reports: H1N1 Flu Could Adversely Impact Holiday Shopping Season 2Health News:Nuvo Research responds to increased trading activity 2
DIX foreign body spud 4 3/4 inches, 1.7 x 15 mm blade....
... MMA/VP material and has a high water content ... the base curve and total diameter as specified ... a power range of -30.00DS to +30.00DS,Simplon Bandage ... therapeutic applications including the controlled on-eye delivery of ...
Foreign body spud very thin, lightly curved and rounded tip....
... Manufactured from premium ... with high oxygen permeability. ... design. Recommended for the ... erosions and abrasions. bullous ...
Medicine Products: